CIK: 0001420995 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value ($000): $631,500 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 1,109,343 | $620,555 | 98.3% | $585.18 | — | TR UNIT | 78462F103 |
| NU | NU HLDGS LTD | 909,930 | $9,318 | 1.5% | $12.00 | -1.5% | ORD SHS CL A | G6683N103 |
| SRZN | SURROZEN INC | 47,930 | $559 | 0.1% | $6.97 | +66.7% | COM | 86889P208 |
| — | VIGIL NEUROSCIENCE INC | 192,973 | $343 | 0.1% | $0.01 | — | COM | 92673K108 |
| QTTB | Q32 BIO INC | 133,903 | $221 | 0.0% | $31.58 | -91.5% | COM | 746964105 |
| XLO | XILIO THERAPEUTICS INC | 249,635 | $181 | 0.0% | $2.41 | -62.8% | COM | 98422T100 |
| TNYA | TENAYA THERAPEUTICS INC | 291,828 | $166 | 0.0% | $21.49 | -95.4% | COM | 87990A106 |
| — | RAPT THERAPEUTICS INC | 73,383 | $90 | 0.0% | $20.30 | — | COM | 75382E109 |
| — | VOR BIOPHARMA INC | 91,910 | $66 | 0.0% | $43.10 | — | COM | 929033108 |
| SRZNW | SURROZEN INC | 33,333 | $1 | 0.0% | $1.14 | — | *W EXP 08/01/2 | 86889P117 |